Tag Archives: pain

Insecure Teens Feel More Pain, Are More Likely to Be Anxious

Posted on by
Reply

December 8, 2009 — Insecure adolescents feel more intense pain and are more likely to be anxious and depressed than their secure counterparts, new research suggests.

The results of a large survey study suggest that interventions, such as cognitive behavioral therapy (CBT), that target certain attachment styles might be beneficial in teens.

“We might need to start to look at interpersonal factors like attachment styles if we want to create lasting changes in our interventions,” study author Michael J. L. Sullivan, PhD, McGill University, Montreal, Quebec, Canada, told Medscape Psychiatry.



The study was published online October 23 in the Journal of Pain.

For the study, researchers analyzed questionnaire responses from 382 high school students (223 female and 159 male). Participants were in grades 8 to 12 and had a mean age of 14.4 years.

To determine frequency and intensity of pain symptoms, researchers asked students how many times they had experienced 10 of the most frequent types of pain during the last 10 months and to rate the pain severity on an 11-point scale.

Researchers used another questionnaire to assess pain “catastrophizing” or the tendency to see symptoms as threatening or stressful. Students indicated the frequency with which they experienced each of 13 pain-related thoughts or feelings on a 5-point scale. The scale measures rumination, magnification, and helplessness.

Investigators also used the 18-item Adolescent Relationship Scale Questionnaire to assess attachment styles of students.

These styles included:

• Secure (finding it easy to get emotionally close to others);

• Preoccupied (wanting to be completely emotionally close with others);

• Fearful (worrying about being hurt if too close to others); and

• Dismissing (finding it very important to feel independent).

Students also completed questionnaires to measure the severity of symptoms of anxiety and depression.

Girls Feel More Pain

Girls in the study reported greater pain severity, pain catastrophizing, and depression than boys and had higher scores on the rumination, magnification, and helplessness subscales. Boys scored higher than girls on dismissing attachment style.

The study found various relationships between attachment styles and anxiety, depression, and pain. A secure attachment style was associated with low levels of pain catastrophizing, anxiety, pain severity, and depression, whereas preoccupied and fearful attachment styles were associated with heightened pain catastrophizing, anxiety, pain severity, and depression.

“When you start to interpret your symptoms in a more alarmist or threatening fashion, there’s a whole cascade of negative psychological and physiological events that can occur,” said Dr. Sullivan.

“If you’re experiencing pain, the more you attend to it the more you’re actually going to be experiencing more intense pain and the more you’re going to be focusing on the negative aspects of your symptoms. Over time, that might also have a wearing effect on your mood, leading to increases in anxiety and depression.”

Results Helpful

Although it is probably expected that a secure attachment is linked to lower levels of anxiety and depression, the finding that this attachment style is related to pain severity was surprising, said Katie Cullen, MD, assistant professor of psychiatry, University of Minnesota Medical School, Minneapolis. “We wouldn’t necessarily have known what to expect with the pain, so that was really helpful,” she said.

Dr. Cullen, who was not involved in the study, runs a depression clinic, whereas her colleague, Gail A. Bernstein, MD, professor and head, Program in Child and Adolescent Anxiety and Mood Disorders, University of Minnesota Medical School, runs an anxiety clinic. Young people often present to both clinics with pain symptoms.

Insecure adolescents experience more intense pain in the form of frequent headaches, abdominal pain, and joint pain. About 20% to 25% of adolescents experience recurrent or chronic pain, according to background information in the study.

Dr. Cullen said this statistic is potentially useful in raising awareness among specialists treating teens.

In discussing the physiological mechanisms by which catastrophic thinking might influence pain severity, the study authors note that high catastrophizing has been linked to lower pain threshold and lower pain tolerance. Those with high catastrophizing show enhanced activity in brain regions involved in anticipating and attention toward pain.

Move Beyond Current CBT Model

In this study, anxiety also tended to mediate the relationship between attachment styles and both pain severity and depression. These findings suggest that anxiety, pain catastrophizing, and attachment styles are related processes that make independent contributions to the prediction of pain severity and depression.

Although the study looked at attachment styles of teenagers, these styles typically begin in infancy. “There are still a lot of holes in our knowledge in this area, but there are some fairly strong indications that the style of attachment that you develop with your parents early on is something that follows you through the rest of your life,” said Dr. Sullivan.

The study results could affect the type of interventions used to treat teens. Current cognitive behavioral interventions focus on altering catastrophic thinking but not on attachment styles that drive that thinking. Often, the positive results from such therapy do not last, said Dr. Sullivan. “This suggests that while catastrophizing is definitely one of the factors contributing to negative outcomes, it might not be the ultimate source.”

He added that it is important to “move beyond” current CBT models that might be overly simplistic. “I would strongly suspect that over the next decade, we will start to see a lot more research looking at how different interpersonal processes impact on health outcomes.”

Dr. Bernstein said she found the results “intriguing and interesting” and the sample size “impressive.” “They have a big enough sample to be drawing some conclusions, and I think it’s something that will perhaps lead to further exploration in this area.”

The authors have disclosed no relevant financial relationships.

Journal of Pain. Published online October 23, 2009.

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Men with Fibromyalgia

Posted on by
Reply
This entry is part of a series, men with fibro»

For generations women had a tough time convincing doctors to take them seriously for many medical conditions, especially Fibromyalgia. Women have been called hysterical and told to curtail their active imaginations. However, men with Fibromyalgia are
dealing with an entirely different issue; they just don’t talk about it. Can you blame men for not coming forward with a woman’s disease when she is being told that it’s all in her head?

Now, let me tell you a little about this serious syndrome for both men and woman. Not necessarily the facts the doctors give you, but how the sufferers perceive it. Do you remember the flu that kept you from getting up out of bed for two weeks? Remember how difficult it was getting up out of bed and going to the bathroom? You were tired, uncomfortable, and ached all over, so you took medication to sleep. Now, I want you to imagine two things. First, you have no medication to ease the flu symptoms and second, the flu never goes away. In fact, Fibromyalgia does progress, not only does your pain and fatigue increase, other symptoms start appearing, regardless of whether you are a man or a woman.


With men, these flu-like symptoms manifest themselves a little differently at first because of gender roles and the physical differences between men and women. Men don’t go to doctors and often become stoic, hiding symptoms. Additionally, men have a tendency to isolate more than women and don’t want to be seen as whiners. They often wait until they can’t function at all before seeking medical attention. Fibromyalgia is sometimes called the invisible disability and for men this is especially true. I talked to Ron Mesic, Michigan, who began suffering with fibromyalgia as a teen. Ron said, “I seriously suspect that when I started seeking help, the prevailing attitude of medical professionals was that men should be tough, and importantly – modern medicine doesn’t cure much, they just make the patient comfortable while the body cures itself.”

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

$100 Million for Innovative Lupus Research

Posted on by
Reply

December 8, 2009—It was announced last night that over the past decade, the Lupus Research Institute (LRI)’s pioneering science has generated $100 million in new research funding for the devastating autoimmune disease of systemic lupus.

“In powering unprecedented scientific discovery, the LRI has forever changed the field of lupus research,” said LRI Board Member Richard K. DeScherer at the annual S.L.E. Lupus Foundation gala in New York. “LRI scientists have turned $30 million dollars in initial LRI grant funding into $70 million more from the National Institutes of Health (NIH).

“That’s what we call a breakthrough decade!” he said. “An incredible $100 million dollars for entirely new science in lupus–-innovative work that would not exist without the LRI taking risks on the most brilliant scientific minds in the country.”

“The LRI strategy of funding novel scientific ideas in lupus has more than demonstrated its power,” said William E. Paul, MD, chief of the Laboratory of Immunology at NIAID-NIH, and chair of the LRI Scientific Advisory Board. “The LRI model strengthens the lupus research landscape by moving novel concepts forward to secure large-scale federal funding.”

“The speed with which the Institute has changed the outlook for lupus research is remarkable,” Dr. Paul said.

The LRI selects Novel Research Grant awards based on creativity, novelty, and potential to drive scientific discovery. To date, the Institute has awarded $30 million to 108 investigators at 55 academic medical centers across 22 states.

More than 65 percent of LRI-funded researchers have gone on to win extended funding from the NIH to further pursue their work, including:

* Betty Diamond, MD, at the Feinstein Institute for Medical Research (North Shore-LIJ Health System) in New York. The LRI funded Dr. Diamond’s initial work on the role of stress hormones in allowing toxic antibodies to penetrate the brain in lupus and destroy nerve cells there, causing memory loss, confusion, and other cognitive problems. She went on to receive an NIH program grant for $6.5 million to build on strategies to deal with this devastating development.
* Marcus Clark, MD, at the University of Chicago. With LRI funding, Dr. Clark showed that the kidneys of people with lupus actually contain the activated B cells that directly promote inflammation and damage in these critical organs. The NIH provided an additional $1.7 million to further explain and expand on this major discovery. “This government grant was funded based entirely on research supported by the LRI,” Dr. Clark said.
* Greg E. Lemke, PhD, at La Jolla, California’s Salk Institute for Biologic Studies. Dr. Lemke proposed the novel idea that a curious family of “TAM” receptors might function as a core ‘control switch’ over the immune system’s inflammatory response. He received an additional $1.4 million from the NIH and others to explore exciting new approaches to shutting down the uncontrolled inflammation of lupus by restoring immune system regulation. “Without the LRI, this project would have stopped—and a fundamental discovery in immunology would not have happened,” Dr. Lemke said.

“What an incredible investment the LRI has been,” said LRI Co-Chairman Robert J. Ravitz. “It has paid off in a decade of stellar return on results that matter for people with lupus, and my wife and I now have such hope that our daughter Annie and millions of others will soon have answers on how to stop lupus.”

LRI President Margaret G. Dowd added, “We are so very grateful to our supporters for believing and investing in LRI’s powerful research model for breakthroughs in lupus. Their bold commitment is enabling innovative science to successfully blaze the path to a cure and a hope-filled new decade for people with this devastating disease.”

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

What are the disadvantages and side effects of cortisone injections?

Posted on by
Reply

Disadvantages of cortisone injections are the necessity of piercing the skin with a needle as well as potential short- and long-term side effects. It should be emphasized that though each of these side effects is possible, they usually do not occur.

Short-term side effects are uncommon but include shrinkage (atrophy) and lightening of the color (depigmentation) of the skin at the injection site, introduction of bacterial infection into the body, local bleeding from broken blood vessels in the skin or muscle, soreness at the injection site, and aggravation of inflammation in the area injected because of reactions to the corticosteroid medication (postinjection flare). Tendons can be weakened by corticosteroid injections in or near tendons. Tendon ruptures as a result have been reported.

In people who have diabetes, cortisone injections can elevate the blood sugar. In patients with underlying infections, cortisone injections can suppress somewhat the body’s ability to fight the infection and possibly worsen the infection or may mask the infection by suppressing the symptoms and signs of inflammation. Generally, cortisone injections are used with caution in people with diabetes and avoided in people with active infections. Cortisone injections are used cautiously in people with blood-clotting disorders.

Long-term side effects of corticosteroid injections depend on the dose and frequency of the injections. With higher doses and frequent administration, potential side effects include thinning of the skin, easy bruising, weight gain, puffiness of the face, elevation of blood pressure, cataract formation, thinning of the bones (osteoporosis), and a rare but serious damage to the bones of the large joints (avascular necrosis).

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Doc’s Fibromyalgia Story Part 2

Posted on by
Reply
This entry is part of a series, docs story»

Many things have been going on since I last updated my post. After7 months or so the Imipramine stopped working for my fibro pain. I hate when that happens, you just get use to something and bam, you have to start over.
We decided to give Cymbalta a try. The doctor more than me, I have heard many bad stories about Cymbalta, but we are all different so I went along with trying it.

At 30 mg twice a day, the pain had lessened to a 4/5 but after a few months I was starting to get a little bitchy. The doc upped it to 60 mg twice a day and the feeling bitchy went away but I was not feeling anything but my pain. I was numb, a zombie …

After fighting so hard to get the insurance to pay for the Cymbalta, I now new I would have to stop using it and try again..

In the mean time, my blood sugar levels, which had been fine for years are now running very high, My doctor has added medication, pills for now to help control the glucose levels and I cant seem to shake this extra 30 lbs I am carrying

On the Fibro front, I am now taking the newest medication, Savella 50mg twice daily, this med has been approved and used in Europe for 5 or more years, but it is new here in the States.

I must admit, the Fibro and Neuropathy pains are almost gone !!!!! My head is a lot clearer, and I feel like myself not some Zombie.. I get angry, I get happy.. this is good!

The Cymbalta required a withdrawal, that the makers do not admit to. I had to reduce the amount slowly to avoid the painful headaches and stomach aches. Then there is the brain zaps ! don’t know what else to call them, all of a sudden its like an electric shock in the brain, happens more when you twist your head or even your eyes! Well they are not as frequent now, It has been a month! that’s it for now!

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Entries in this series:
  1. Docs Fibromyalgia Story
  2. Doc's Fibromyalgia Story Part 2
Powered by Hackadelic Sliding Notes 1.6.5

Severe And Chronic Pain In Multiple Areas Associated With Increased Risk Of Falls In Older Adults

Posted on by
Reply

Older adults who reported chronic musculoskeletal pain in two or more locations, higher levels of severe pain, or pain that interfered with daily activities were more likely to experience a fall than adults who did not reports these types of pain, according to a study in the November 25 issue of JAMA.

“Falls rank among the 10 leading causes of death in older adults in the United States, resulting in more than $19 billion in health care costs annually. Despite a growing body of scientific evidence supporting associations between a number of risk factors and falls, efforts to translate these findings into effective fall prevention strategies have been limited,” the authors write. Few reports have examined chronic pain as a risk for falls in older adults. “Pain contributes to functional decline and muscle weakness and is associated with mobility limitations that could predispose to falls.”

Suzanne G. Leveille, Ph.D., R.N., of Beth Israel Deaconess Medical Center and the University of Massachusetts-Boston, and colleagues conducted a study to determine whether chronic musculoskeletal pain is associated with an increased occurrence of falls in older adults. The study included 749 adults, age 70 years and older, who were enrolled in the study from September 2005 through January 2008. Pain was assessed via questionnaires. Participants recorded falls on monthly calendar postcards mailed to the study center during an 18-month period.

At the beginning of the study, 40 percent of participants reported chronic pain in more than one joint area and 24 percent reported chronic pain in only one joint area. A total of 1,029 falls were reported by the 749 participants during and up to 18 months of follow-up. Four hundred five participants (55 percent) fell at least once during the follow-up. Analysis indicated that compared with participants who reported no pain or those in the lowest groups of pain scores, participants who reported two or more sites of pain had an increased risk for falls; those reporting the highest levels of pain severity also had an increased rate of falls; and pain interference with activities was also associated with a greater occurrence of falls.

The researchers write that they observed a strong graded relationship in the short term between pain severity ratings each month with risk for falls in the subsequent month. “For example, among persons who reported severe or very severe pain for any given month on their calendar postcard, there was a 77 percent increased likelihood for a fall in the subsequent month compared with those who reported no pain.” Persons reporting even very mild pain also had an elevated odds of falling in any given month.

The authors suggest there may be several possible mechanisms for the pain-falls relationship, including neuromuscular effects of pain, which could lead to leg muscle weakness or slowed neuromuscular responses to an impending fall. “Another factor may be gait alterations or adaptations to chronic pain that lead to instability and subsequent balance impairments. Chronic pain may serve as a distractor or, in some way, interfere with cognitive activity needed to prevent a fall. Successful avoidance or interruptions of a fall typically requires a cognitively mediated physical maneuver.”

“The findings provide evidence suggesting that the common complaint of the aches and pains of old age is related to a greater hazard than previously thought. Daily discomfort may accompany not only difficulties in performing daily activities but equally as important may be a risk for falls and possibly fall-related injuries in the older population. The significance of this work is in the identification of chronic pain as an overlooked and potentially important risk factor for falls in older adults. A randomized controlled trial is needed to determine whether improved pain control could reduce risk for falls among older patients with chronic pain,” the researchers conclude.

JAMA. 2009;302[20]:2214-2221.

Source
Journal of the American Medical Association

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Fibromyalgia – Why is it Controversial illness?

Posted on by
Reply

Fibromyalgia, also known as FM or FMS, is similar to rheumatism, but is distinguished from other rheumatic conditions like tendinitis or bursitis because the discomfort and stiffness is widespread, while in tendinitis or bursitis the pain is localized to a categorical area. It is characterized by protracted discomfort all over the body with multiple tender points, serious fatigue, sleep Problems, anxiousness and depression and all can be happening at the same time. The precise reason for fibromyalgia isn’t known, and ladies are ten times surer to notice the effects of FM than men.

Fibromyalgia is categorized as either first or secondary. Idiopathic fibromyalgia is another name for the primary form. The secondary form of this debilitating disease is due to several conditions such as cancer, lupus, hypothyroidism, or HIV, as well as any kind of physical trauma.


Fibromyalgia is a major neurological condition that causes discomfort in the musculoskeletal system. A main characteristic of fibromyalgia is an obvious state of fatigue that takes over the entire body. Though the discomfort reported by people with fibromyalgia is present, it happens in-house of unusual brain activity.

Fibromyalgia Controversy

Fibromyalgia is a very debatable disorder among the medical community. Doctors having differing viewpoints about the particular causes and risk factors of the illness. Although the discusses continue upon this matter, a discovery implies that fibromyalgia is in fact a neurological disorder. While some groups of medical scientists theorize that fibromyalgia is actually a purely psychological disorder. These groups say that the symptoms, such as joint rigidity, muscle pain and stiffness, and generalized fatigue, are self-induced.

Other groups believe that the disorder has a clear medical background and its symptoms are of neurological cause. Fibromyalgia is often called a confusing illness. Adding fire to this debate was an article that appeared in the New York Times that recommended that fibromyalgia is not real. This targeted on the small minority of doctors who feel that those diagnosed with FMS are in truth simply very lazy, depressed, or funny. However, research that has been conducted on the disorder has it gaining respect in both the scientific and the lay community as being extraordinarily real. These studies show that not only is it a real illness, but there are drugs that properly treat it. Thanks to the studies, Fibromyalgia is recognized by not only the American College of Rheumatology and the Social Security Administration, but the North American Medical Association also.

One way or another, and controversy or debate aside, fibromyalgia is very real to those who suffer from it. It is unfair to these people to downplay this disease, as many are completely and totally incapacitated from it. They can no longer live normal lives, and luckily in the United States at least, they can now receive compensation from the Social Security Administration. This process can take years though, and during that time lives can be seriously adversely affected by wages lost, among other things.
Hopefully, in time, there will be a cure for them.

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Fibromyalgia Patients Show Decreases In Gray Matter Intensity

Posted on by
Reply

ScienceDaily (June 18, 2009) — Previous studies have shown that fibromyalgia is associated with reductions in gray matter in parts of the brain, but the exact cause is not known. Using sophisticated brain imaging techniques, researchers from Louisiana State University, writing in The Journal of Pain, found that alterations in levels of the neurotransmitter dopamine might be responsible for gray matter reductions.

For the study, magnetic imaging resonance data from 30 female fibromyalgia patients were compared with 20 healthy women of the same age. The primary objective of the study was to confirm original findings about reduced gray matter density in a larger sample of fibromyalgia patients. They explored whether there is a correlation between dopamine metabolic activity and variations in the density of gray matter in specific brain regions.

Results showed there were significant gray matter reductions in the fibromyalgia patients, which supports previous research. In addition, the fibromyalgia patients showed a strong correlation of dopamine metabolism levels and gray matter density in parts of the brain in which dopamine controls neurological activity.

The authors concluded that the connection between dopamine levels and gray matter density provide novel insights to a possible mechanism that explains some of the abnormal brain morphology associated with fibromyalgia.

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

Nutra Pharma Announces Launch of Cobroxin, an Over-the-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain

Posted on by
Reply

PLANTATION, Fla.–(BUSINESS WIRE)–Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.

Cobroxin is the first OTC pain reliever clinically proven to treat Stage 2 (moderate to severe) chronic pain. The drug, which was developed by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm, will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating repetitive stress, arthritis, and joint pain.

Additional benefits to Cobroxin include:

* All Natural
* Non-Addictive
* Non-Narcotic
* Non-Opiate
* More Potent than Morphine
* Long Lasting

“Cobroxin is a next generation pain reliever that addresses physician and consumer demand for a safer and less costly treatment for chronic pain,” commented Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “Cobroxin provides affordable and accessible pain relief for those without healthcare coverage, for those looking for a safer and effective treatment for pain, and for those not receiving effective or lasting relief from OTC NSAIDs,” he added.


Pain is the single most common reason patients seek medical care and accounts for half of all physician office visits in the United States. According to the American Pain Foundation, each year, more than 25 million people in the United States experience acute pain as a result of injury or surgery. Additionally, more than 50 million people in the United States are affected by ongoing chronic pain.

Current treatments for chronic pain include both opiate-based analgesics including Vicodin, Percocet, and Morphine, and those containing acetaminophen, such as Tylenol. Debate surrounding the use of opiates primarily focuses on the negative side effects observed with opiate-based analgesics, including nausea, vomiting, drowsiness, itching, constipation, respiratory depression, addiction, severe withdrawal symptoms and the buildup of tolerance, requiring higher dosage over time to experience the same effect. Additionally, recent media coverage has highlighted the dangers of using analgesics containing acetaminophen, which, in higher dosages, can cause liver damage or even death.

“What differentiates Cobroxin from other current analgesics is that it uses a novel mechanism of action discovered from cobra venom peptides for treating pain without the negative side effects observed in current opiate-based analgesics and those containing acetaminophen,” explained Dr. Paul Reid, CEO of Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm. “With extensive supporting evidence from 46 human clinical studies and a well-defined safety profile, we believe that Cobroxin will soon become the preferred method for treating chronic pain,” he concluded.

In preparation for commercializing Cobroxin, Nutra Pharma recently announced that ReceptoPharm had filed a patent application for a novel composition and method for oral delivery of cobra venom for the treatment of pain. The company plans to begin marketing and selling Cobroxin upon successful submission of final packaging and labeling to the FDA.

About Nutra Pharma Corp.

Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis (“MS”). The Company’s subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Paratuberculosis (para-TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post

What is sciatica?

Posted on by
Reply

What is sciatica?

Sciatica is pain, tingling, or numbness produced by an irritation of the nerve roots that lead to the sciatic nerve. The sciatic nerve is formed by the nerve roots coming out of the spinal cord into the lower back. Branches of the sciatic nerve extend through the buttocks and down the back of each leg to the ankle and foot.
What causes sciatica?

The most common cause of sciatica is a bulging or ruptured disc (herniated disc) in the spine pressing against the nerve roots that lead to the sciatic nerve. But sciatica also can be a symptom of other conditions that affect the spine, such as narrowing of the spinal canal (spinal stenosis), bone spurs (small, bony growths that form along joints) caused by arthritis, or nerve root compression (pinched nerve) caused by injury. In rare cases, sciatica can also be caused by conditions that do not involve the spine, such as tumors or pregnancy.
What are the symptoms?

Symptoms of sciatica include pain that begins in your back or buttocks and moves down your leg and may move into your foot. Weakness, tingling, or numbness in the leg may also occur.

* Sitting, standing for a long time, and movements that cause the spine to flex (such as knee-to-chest exercises) may make symptoms worse.
* Walking, lying down, and movements that extend the spine (such as shoulder lifts) may relieve symptoms.


How is sciatica diagnosed?

Sciatica is diagnosed with a medical history and physical exam. Your doctor will ask you questions about your symptoms. And your doctor may be able to tell just by asking you these questions that you have sciatica, but X-rays and tests such as magnetic resonance imaging (MRI) are sometimes done to help find the cause of the sciatica.
How is it treated?

In many cases, sciatica will improve and go away with time. Initial treatment usually focuses on medicines and exercises to relieve pain. You can help relieve pain by:

* Avoiding sitting (unless it is more comfortable than standing).
* Alternating lying down with short walks. Increase your walking distance as you are able to without pain.
* Taking acetaminophen (Tylenol) or nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve).
* Using a heating pad on a low or medium setting, or a warm shower, for 15 to 20 minutes every 2 to 3 hours. You can also try an ice pack for 10 to 15 minutes every 2 to 3 hours. There is not strong evidence that either heat or ice will help, but you can try them to see if they help you.

Additional treatment for sciatica depends on what is causing the nerve irritation. If your symptoms do not improve, your doctor may suggest physical therapy, injections of medicines such as steroids, or even surgery for severe cases.

Post to Twitter Post to Delicious Delicious Post to Digg Digg This Post Post to Facebook Facebook Post to StumbleUpon Stumble This Post